We look for global demographic trends — aging populations in developed nations and the rapid urbanization of developing countries — to fuel long-term growth of St. Jude Medical (STJ). These trends give rise to growing demand for cardiovascular health care.

However, recent weaknesses in the CRM segment, particularly in the U.S., are headwinds for St. Jude in the near-term. This might force the company to lose market share to its competitors.

Earnings per share in the third quarter reached $0.59, beating the Zacks Consensus Estimate by one cent. However, we have chosen to downgrade the stock to an Underperform with a target price of $31.

Zacks Investment Research

1. (STJ) St. Jude Medical Beats Earnings EstimatesSt. Jude Medical, Inc. (STJ) today reported financial results for the third quarter of 2009...
2. (STJ) St. Jude Medical Earns New Device ApprovalSt. Jude Medical, Inc. (STJ) received the CE (Conformite Europeenne) Mark of approval for the...
3. (STJ) St. Jude Medical Eyeing AcquisitionsSt. Jude Medical Inc. (STJ) recently made a $15 million equity investment in Micell Technologies,...
4. (STJ) St. Jude Medical – PressureWire Aeris is a SuccessSt. Jude Medical Inc. (STJ) announced the first use of its PressureWire Aeris technology, an...
5. (STJ) St. Jude Medical Receives FDA ApprovalSt. Jude Medical, Inc. (STJ) received U.S. Food and Drug Administration (FDA) clearance for the...
6. (STJ) St. Jude Medical Receives Product ApprovalSt. Jude Medical, Inc. (STJ) received the CE (Conformite Europeenne) Mark approval for the world’s...

Search Posts by Tag: St. Jude Medical Inc | STJ | Healthcare | Medical Appliances & Equipment

RSS Feeds by Tag: St. Jude Medical Inc | STJ | Healthcare | Medical Appliances & Equipment |

Other Posts by: vitalstocks | RSS Feed for this author